SCHEMBL540915

SCHEMBL540915

Nc1ccc(NS(=O)(=O)c2ccc(N)cc2)cc1

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 5/20 0.85
CA2 P00918 5/20 0.85
CA9 Q16790 3/20 0.85
HTT P42858 1/20 0.85
KMT2A Q03164 4/20 0.81
KEAP1 Q14145 1/20 0.81
MEN1 O00255 3/20 0.73
ALDH1A1 P00352 2/20 0.73
PRMT1 Q99873 1/20 0.73
CYP1A2 P05177 1/20 0.73
CYP3A4 P08684 1/20 0.73
MAPT P10636 1/20 0.73
CYP2C19 P33261 1/20 0.73
HTR6 P50406 2/20 0.67
CES1 P23141 1/20 0.63
PKM P14618 1/20 0.63
CA12 O43570 2/20 0.62
AKT1 P31749 1/20 0.59
MMP1 P03956 1/20 0.59
MMP2 P08253 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11793140 1.00 CA1 (0.85) CA1CA2CA9HTTKMT2A
SCHEMBL19603195 0.94 CA1 (0.76) CA1CA2CA9HTTKMT2A
SCHEMBL153131 0.92 CA1 (1.00) CA1CA2CA9HTTKMT2A
SCHEMBL1417537 0.90 CA1 (0.71) CA1CA2CA9HTTKMT2A
SCHEMBL11683906 0.90 CA1 (0.71) CA1CA2CA9HTTKMT2A
SCHEMBL3086764 0.90 CA1 (0.74) CA1CA2CA9HTTKMT2A
SCHEMBL2240008 0.90 CA1 (0.71) CA1CA2CA9HTTKMT2A
SCHEMBL4573594 0.90 CA1 (0.74) CA1CA2CA9HTTKMT2A
SCHEMBL29118838 0.90 PRMT1 (0.90) CA1CA2CA9HTTKMT2A
SCHEMBL29246542 0.90 HTT (0.71) CA1CA2CA9HTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 413 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4251672-B1 POLYMERIC MANNICH BASE, PREPARATION METHODS AND USE AS AN EPOXY RESIN CURATIVE JONES PAUL (GB) 2025-09-24 EP claimed
US-20240026067-A1 POLYMERIC MANNICH BASE, PREPARATION METHODS AND USE AS AN EPOXY RESIN CURATIVE JONES PAUL (GB) 2024-01-25 US claimed
WO-2023233151-A1 PROCESS FOR PREPARING BIO-BASED CURED EPOXY RESIN, AND BIO-BASED RESINS OBTAINABLE THEREFROM JONES PAUL (GB) 2023-12-07 WO claimed
US-20230357489-A1 MANNICH BASE EPOXY CURATIVE, CURED EPOXY RESINS THEREOF AND METHODS OF PREPARING THE SAME JONES PAUL (GB) 2023-11-09 US claimed
EP-4251672-A1 POLYMERIC MANNICH BASE, PREPARATION METHODS AND USE AS AN EPOXY RESIN CURATIVE Jones, Paul (GB) 2023-10-04 EP claimed
EP-4097164-B1 MANNICH BASE EPOXY CURATIVE, CURED EPOXY RESINS THEREOF AND METHODS OF PREPARING THE SAME JONES PAUL (GB) 2023-08-23 EP claimed
EP-4097164-A1 MANNICH BASE EPOXY CURATIVE, CURED EPOXY RESINS THEREOF AND METHODS OF PREPARING THE SAME Jones, Paul (GB) 2022-12-07 EP claimed
WO-2022112776-A1 POLYMERIC MANNICH BASE, PREPARATION METHODS AND USE AS AN EPOXY RESIN CURATIVE JONES PAUL (GB) 2022-06-02 WO claimed
WO-2021152281-A1 MANNICH BASE EPOXY CURATIVE, CURED EPOXY RESINS THEREOF AND METHODS OF PREPARING THE SAME JONES PAUL (GB) 2021-08-05 WO claimed
US-10189938-B2 Polyurea composition SIKA TECHNOLOGY AG (CH) 2019-01-29 US claimed
EP-4737500-A1 RAPID CURE EPOXY RESIN HARDENERS Jones, Paul (GB) 2026-05-06 EP disclosed
EP-4721970-A1 BONDED STRUCTURE COMPRISING AN ELECTROCHEMICALLY DEBONDABLE ADHESIVE LAYER Henkel AG & Co. KGaA (DE) 2026-04-08 EP disclosed
EP-4721971-A1 METHOD OF SEPARATING BONDED ARTICLES Henkel AG & Co. KGaA (DE) 2026-04-08 EP disclosed
EP-4717746-A1 ONE COMPONENT (1K) COMPOSITION BASED ON EPOXIDE COMPOUNDS Henkel AG & Co. KGaA (DE) 2026-04-01 EP disclosed
US-12590207-B2 Epoxy composition comprising a bio-based epoxy compound HENKEL AG & CO. KGAA (DE) 2026-03-31 US disclosed
EP-0731144-A2 Azo dyes, their production and use Clariant Finance (BVI) Limited (VG) 1996-09-11 EP disclosed
US-5240499-A Polymeric pigments HOECHST AKTIENGESELLSCHAFT (DE) 1993-08-31 US disclosed
EP-0492501-A1 Surface-active triazine compounds, process for their preparation and their use HOECHST AKTIENGESELLSCHAFT (DE) 1992-07-01 EP disclosed
CN-1031537-A Polymorphic forms of xanthosine and methods of use thereof GORDON PAUL (US) 1989-03-08 CN disclosed
US-4479906-A BLACK LEATHER DYE BASF AKTIENGESELLSCHAFT (DE) 1984-10-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12590207-B2 Epoxy composition comprising a bio-based epoxy compound ITGA6, O60361, ITGB6 CA1 2811/4885CA2 4107/4885CA9 3857/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.